NR4A1 and neoplasm: Median age at randomisation was 67·1 years (IQR 61·5–74·8), 2536 (57%) of 4480 patients had a tumour size up to 2 cm, and all but eight (<1%) patients were confirmed locally to have hormone receptor-positive tumours (table 1).